Boule Diagnostics AB will publish the year-end report for the period January–December 2020 at 15:00, Wednesday, February 3rd, 2021. Following the publication, Boule will hold a Teams Live Event at 16:00 for media and investors.
CEO Jesper Söderqvist and CFO Christina Rubenhag will present and comment on the year-end report. After the presentation there will be time for audience questions. The presentation will be held in English.
Time: 16:00 CET, Wednesday, February 3rd, 2021
Please use this link to attend!
The year-end report will be accessible at http://www.boule.com when published.
Please feel free to attend this event!
For further information, please contact:
Jesper Söderqvist, CEO and Group President, Boule Diagnostics AB, phone +46 (0)70-689 05 90
Christina Rubenhag, CFO, Boule Diagnostics AB, phone +46 (0)70-546 72 22
About Boule Diagnostics AB (publ)
Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011. www.boule.com
The information was submitted for publication, through the agency of the contact person set out above,
at 15.00 CET on February 1, 2021.
This release was sent by Cision